vTv Therapeutics Inc.
VTVT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | -29.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -25,970.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -21,376.5% |
| EPS Diluted | -1.08 | -0.92 | -0.77 | -0.63 |
| % Growth | -17.4% | -19.5% | -22.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |